Papaioannou quoted in Harvard Business Review
Innogen’s Theo Papaioannou of the Open University was quoted in the Harvard Business Review July – August 2012.
As a leading scholar on public policy and political theory in the area of governance of innovation and development, Dr Theo Papaioannou of Innogen at the Open University was recently quoted in the Harvard Business Review Magazine.
In the article entitled, “Why Life Science Needs Its Own Silicon Valley,” Papaioannou was quoted under under the section on ‘Making Clusters Happen’:
“One factor does seem to be important for cluster creation, however: government support. The movie industry in Vancouver, which employs almost 50,000 people and contributes more than $1 billion annually to British Columbia’s economy, has benefited enormously from tax incentives and other forms of government cooperation. But financial incentives are only part of the story. Governments can also make a difference by providing such things as infrastructure, demand for products, and incentives and avenues for knowledge building. In the 1990s, in support of a biotech cluster in Cambridge, England, the British government funded an intellectual infrastructure of sorts—a networking organization known as the Eastern Region Biotechnology Initiative, which provided a means for industry participants to meet and interact, according to Theo Papaioannou, of the Open University’s Innogen Centre. The cluster ultimately grew to include more than 200 companies, 30 research institutes, and four research hospitals. A smaller and more widely dispersed biotech cluster around Dundee (the jute industry faded away long ago) was supported by the Scottish government.”
The article was written by Fariborz Ghadar, the William A. Schreyer Professor of Global Management at Pennsylvania State University’s Smeal College of Business; John Sviokla, principal in the Strategy & Innovation practice at PwC Consulting; and Dietrich A. Stephen, member of the board of directors of the Personalized Medicine Coalition.